Impact Evaluation of the Use of Community Volunteers and Patent Medicine Vendors for Malaria Control in Anambra State and Gombe State 2014 -2015, Endline Survey
Nigeria, 2014 - 2015
Get MicrodataCreated on
Jan 16, 2021
Last modified
Jan 16, 2021
Page views
78152
Downloads
510
BRAND NAME, INCLUDING DRUG SPECIFICATIONS (brandname_drug7)
Data file: pmv_release
Overview
Valid:
33
Invalid:
0
Type:
Discrete
Start:
5558
End:
5601
Width:
44
Range:
-
Format:
character
Questions and instructions
Categories
| Value | Category | Cases | |
|---|---|---|---|
| Amalar ( sp ) | 2 |
6.1%
|
|
| Amalar(SP) | 1 |
3%
|
|
| Amatem | 1 |
3%
|
|
| Artemf ACT | 1 |
3%
|
|
| Artesunat-plus( Artesunate and Amodiaquine ) | 1 |
3%
|
|
| Artesunate 2x2 daily | 1 |
3%
|
|
| Artesunate GMP | 1 |
3%
|
|
| Artesunate(act) | 1 |
3%
|
|
| Camoquin (Amodiaquine) | 1 |
3%
|
|
| Cipla (Lumartem, ACT) | 1 |
3%
|
|
| Laridox ( sp ) | 3 |
9.1%
|
|
| Lever ( Artesunate ) | 1 |
3%
|
|
| Lever (Artesunate ) | 1 |
3%
|
|
| Lonart (ACT) | 1 |
3%
|
|
| Lonart DS ACT | 1 |
3%
|
|
| Lonart-DS (Artemether and Lumefantrine) | 1 |
3%
|
|
| Lumartem | 1 |
3%
|
|
| Lumartem ( Act ) | 1 |
3%
|
|
| METHERINE FORTE | 1 |
3%
|
|
| Malareich | 1 |
3%
|
|
| Malareich ( sp ) | 1 |
3%
|
|
| Maldox SP | 1 |
3%
|
|
| Melofan ( sp ) | 1 |
3%
|
|
| P-Alaxin | 1 |
3%
|
|
| Pymal | 1 |
3%
|
|
| Vinaquine chloroquine sulphate | 1 |
3%
|
|
| Waipa ( ACT ) | 1 |
3%
|
|
| Waipa ( Act ) | 1 |
3%
|
|
| Waipa(ACT) | 2 |
6.1%
|
Warning: these figures indicate the number of cases found in the data file. They cannot be interpreted as summary statistics of the population of interest.